Cargando…
Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. y SEMICYUC.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969860/ https://www.ncbi.nlm.nih.gov/pubmed/33867175 http://dx.doi.org/10.1016/j.medin.2021.03.004 |
| _version_ | 1783666315160977408 |
|---|---|
| author | González-Castro, A. Cuenca Fito, E. Fernandez, A. Escudero Acha, P. Rodríguez Borregán, J.C. Peñasco, Y. |
| author_facet | González-Castro, A. Cuenca Fito, E. Fernandez, A. Escudero Acha, P. Rodríguez Borregán, J.C. Peñasco, Y. |
| author_sort | González-Castro, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7969860 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. y SEMICYUC. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79698602021-03-18 Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2 González-Castro, A. Cuenca Fito, E. Fernandez, A. Escudero Acha, P. Rodríguez Borregán, J.C. Peñasco, Y. Med Intensiva Carta Científica Elsevier España, S.L.U. y SEMICYUC. 2022-05 2021-03-18 /pmc/articles/PMC7969860/ /pubmed/33867175 http://dx.doi.org/10.1016/j.medin.2021.03.004 Text en © 2021 Elsevier España, S.L.U. y SEMICYUC. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta Científica González-Castro, A. Cuenca Fito, E. Fernandez, A. Escudero Acha, P. Rodríguez Borregán, J.C. Peñasco, Y. Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2 |
| title | Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2 |
| title_full | Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2 |
| title_fullStr | Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2 |
| title_full_unstemmed | Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2 |
| title_short | Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2 |
| title_sort | terapia combinada de tocilizumab y corticoides en la enfermedad grave por sars-cov-2 |
| topic | Carta Científica |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969860/ https://www.ncbi.nlm.nih.gov/pubmed/33867175 http://dx.doi.org/10.1016/j.medin.2021.03.004 |
| work_keys_str_mv | AT gonzalezcastroa terapiacombinadadetocilizumabycorticoidesenlaenfermedadgraveporsarscov2 AT cuencafitoe terapiacombinadadetocilizumabycorticoidesenlaenfermedadgraveporsarscov2 AT fernandeza terapiacombinadadetocilizumabycorticoidesenlaenfermedadgraveporsarscov2 AT escuderoachap terapiacombinadadetocilizumabycorticoidesenlaenfermedadgraveporsarscov2 AT rodriguezborreganjc terapiacombinadadetocilizumabycorticoidesenlaenfermedadgraveporsarscov2 AT penascoy terapiacombinadadetocilizumabycorticoidesenlaenfermedadgraveporsarscov2 |